While the mechanisms responsible for cancer protection in LS are yet to be identified, the interpretation of epidemiological data is consistent with the notion that homozygous congenital IGF1 deficiency might confer protection against future development of cancer [28]. This evidence concerns the gene IGF1 and cancer.